Skip to main content
Diseases
Companies
News
Policy
About
Resources
Build with
KISHO
Sign In
Sign Up
Open menu
Kisho
Mannkind Corporation — Rare Disease Pipeline | Kisho | Kisho
Mannkind Corporation
Other
1
Orphan Designations
1
FDA Approvals
2
Rare Diseases
0
News Articles
Pipeline
Designations
News
Diseases
Disease
Drug(s)
Designation
Approved
diabetic ketoacidosis
AFREZZA
-
FDA Approved
pulmonary non-tuberculous mycobacterial infection
clofazimine
Orphan Designation
-
← Back to Companies
